Plasma lipid, lipoprotein and apolipoprotein levels in a random population sample of 2875 Hong Kong Chinese adults and their implications (NCEP ATP-III, 2001 guidelines) on cardiovascular risk assessment

Atherosclerosis

Volumn 184, Issue 2, 2006, Pages 438-445

  Pang, Richard W C ^a   Tam, Sidney ^a   Janus, Edward D ^a,c   Siu, Simon T S ^a   Ma, Oliver C K ^a   Lam, T H ^b   Lam, Karen S L ^b  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Wimmera Base Hospital   (Australia)

Author keywords

Apolipoprotein E; Cardiovascular risk factors; Chinese; Epidemiology; Hong Kong; Lipid profiles; Lipoprotein(a); Postmenopausal

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; DYSLIPIDEMIA; FEMALE; GENE FREQUENCY; GENOTYPE; HONG KONG; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; POSTMENOPAUSE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGED; APOLIPOPROTEINS; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HONG KONG; HUMANS; INCIDENCE; LIPOPROTEINS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION;

EID: 30044443185     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.05.013     Document Type: Article

References (36)

1. Department of Health Annual Report 2000/2001. The Government of Hong Kong Special Administrative Region. Government Publications Centre, Hong Kong.
2. K.M. Anderson, W.P. Castelli, and D. Levy Cholesterol and mortally 30 years of follow-up from the Framingham Study JAMA 257 1987 2176 2180
3. The Sandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
4. J. Danesh, R. Collins, and R. Peto Lipoprotein(a) and coronary heart disease: meta-analysis of prospective studies Circulation 102 2000 1082 1085
5. R. Collins, J. Armitage, S. Parish, P. Sleigh, and R. Peto MRC/BHF heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial Lancet 361 2003 2005 2016
6. J. Otvos What lipids don't tell us about lipoproteins and cardiovascular disease risk? Fat Life 16 3 2002 4 18
7. M.A. Austin, J.E. Hokanson, and K.L. Edwards Hypertriglyceridemia as a cardiovascular risk factor Am J Cardiol 81 1998 7B 12B
8. E. Lau, J. Woo, and C.S. Cockram Serum lipid profile and its association with some cardiovascular risk factors in an urban Chinese population Pathology 25 1993 344 350
9. P.C. Fong, S.C.F. Tam, and Y.T. Tai Epidemiologic studies of the serum lipids and apolipoproteins in Hong Kong Chinese: demographic characteristics and serum lipid and apolipoprotein distribution J Epidemiol Comm Health 48 1994 355 359
10. J. Woo, and CW.K. Lam Serum lipid profile in an elderly Chinese population Arteriosclerosis 10 1990 1097 1101
11. Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
12. T.H. Lam, L.J. Liu, E.D. Janus, C. Bourke, and A.J. Hedley The relationship between fibrinogen and other coronary heart disease risk factors in a Chinese population Atherosclerosis 143 1999 405 413
13. E.D. Janus, N.M.S. Watt, and K.S.L. Lam The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Diab Med 17 2000 741 745
14. S.M. Marcovina, J.J. Albers, L.O. Henderson, and W.H. Hannon International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein A-I values by use of international reference material Clin Chem 39 1993 773 781
15. S.M. Marcovina, J.J. Albers, L.O. Henderson, and W.H. Hannon International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. III. Comparability of apolipoprotein B values by use of international reference material Clin Chem 40 1994 586 592
16. S.C.F. Tam, R.W.C. Pang, E.D. Janus, E.Y.W. Kwan, and L.C.K. Low Growth hormone therapy transiently increases Lp(a) in short β-thalassaemia major children with normal growth hormone reserve Atherosclerosis 128 1997 175 182
17. E. James, J.E. Hixson, and D.T. Vernier Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI J Lipid Res 31 1990 545 548
18. WHO MONICA Project Geographical variation in the major risk factors of coronary heart disease in men and women aged 35-64 years World Health Stat Q 41 1988 115 137
19. W.H. Pan, and B.N. Chiang Plasma lipid profiles and epidemiology of atherosclerotic diseases in Taiwan - a unique experience Atherosclerosis 118 1995 285 295
20. S. Tao, Y. Li, and Z. Ziao Serum lipids and their correlates in Chinese urban and rural populations in Beijing and Guangzhou Int J Epidemiol 21 1992 893 903
21. K. Hughes, P.P.B. Yeo, and K.C. Lun Cardiovascular diseases in Chinese, Malays, and Indians. II. Differences in risk factors J Epidemiol Comm Health 44 1990 29 35
22. T. Dwyer, S.C. Emmanuel, and E.D. Janus The emergence of coronary heart disease in populations of Chinese descent Atherosclerosis 167 2003 303 310
23. D. Bhatnagar, M.I. Mackness, S. Arrol, and P.N. Durrington Preliminary results of a survey of lipid-related coronary risk factors in the Chinese community in Greater Manchester Cardiovascular Risk Factors 2 1992 302 306
24. F. Schiele, D. De Bacquer, and M. Vincent-Viry Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project Atherosclerosis 152 2000 475 488
25. G. Siest, T. Pillot, and A. Regis-Bailly Apolipoprotein E: an important gene and protein to follow in Laboratory Medicine Clin Chem 41 1995 1068 1086
26. H.J. Lenzen, G. Assmann, R. Buchwalsky, and H. Schulte Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol and coronary disease Clin Chem 32 1986 778 781
27. H. Shimano, S. Ishibashi, and T. Murase Plasma apolipoproteins in patients with multiinfarct dementia Atherosclerosis 79 1989 257 260
28. I.A. Larson, J.M. Ordovas, and C. De Luca Association of apolipoprotein (Apo) E genotype with plasma apo E levels Atherosclerosis 148 2000 327 335
29. J.T. Kao, K.S. Tsai, C.J. Chang, and P.C. Huang The effects of apolipoprotein E polymorphism on the distribution of lipids and lipoproteins in the Chinese population Atherosclerosis 114 1995 55 59
30. H.G. Kraft, A. Lingenhel, and R.W.C. Pang Frequency distributions of apolipoprotein(a) levels in Caucasian Asian and African Populations: the distribution of null alleles is non random Eur J Hum Genet 4 1996 78 87
31. R.W.C. Pang, B.S. Chen, E.D. Janus, and K.S.L. Lam Frequency distributions of plasma apolipoprotein(a) levels and phenotypes: a comparison between southern and northern Chinese populations Chin Med J 110 1997 465 473
32. H.G. Kraft, A. Lingenhel, and S. Kohl Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease Arterioscler Thromb Vasc Biol 16 1996 713 719
33. M. Seed, F. Hoppichler, and D. Reaveley Relation of serum lipoprotein(a) concentration and hypercholesterolaemia N Engl J Med 322 1990 1494 1499
34. L.C. Lyu, M.J. Shieh, and J.M. Ordovas Plasma lipoprotein and apolipoprotein levels in Taipei and Framingham Arterioscler Thromb 13 1993 1429 1440
35. C.J. Kim, H.C. Jang, D.H. Cho, and Y.K. Min Effects of hormone replacement on lipoprotein(a) and lipids in postmenopausal women Arterioscler Thromb 14 1994 275 281
36. R.W.C. Pang, and K.S.L. Lam Hormonal influences on lipoprotein(a) metabolism Diab Obes Metab 4 2002 156 165